A new model of experimental subretinal neovascularization in the rabbit

Experimental Eye Research

Volumn 83, Issue 1, 2006, Pages 141-152

  Qiu, Guanting ^a   Stewart, Jay M ^a   Sadda, SriniVas ^a   Freda, Ricardo ^a   Lee, Steven ^a   Guven, Dilek ^a   de Juan Jr , Eugene ^a   Varner, Signe E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

animal model; choroidal neovascularization; fluorescein angiography; macular degeneration; Matrigel; optical coherence tomography (OCT); subretinal delivery

Indexed keywords

MATRIGEL; PHOSPHATE BUFFERED SALINE; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RABBIT; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; CHOROID; CHOROIDAL NEOVASCULARIZATION; COLLAGEN; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; FLUORESCEIN ANGIOGRAPHY; INJECTIONS; LAMININ; PROTEOGLYCANS; RABBITS; RETINA; RETINAL VESSELS; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33646883277     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2005.11.014     Document Type: Article

References (54)

1. Akhtar N., Dickerson E.B., and Auerbach R. The sponge/Matrigel angiogenesis assay. Angiogenesis 5 (2002) 75-80
2. Allikmets R., Shroyer N.F., Singh N., Seddon J.M., Lewis R.A., Bernstein P.S., Peiffer A., Zabriskie N.A., Li Y., Hutchinson A., Dean M., Lupski J.R., and Leppert M. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 277 (1997) 1805-1807
3. Asano T., Shigeno T., Johshita H., Usui M., and Hanamura T. A novel concept on the pathogenetic mechanism underlying ischaemic brain oedema: relevance of free radicals and eicosanoids. Acta Neurochir. Suppl. (Wien) 41 (1987) 85-96
4. Auerbach R., Lewis R., Shinners B., Kubai L., and Akhtar N. Angiogenesis assays: a critical overview. Clin. Chem. 49 (2003) 32-40
5. Browning A.C., Chung A.K., Ghanchi F., Harding S.P., Musadiq M., Talks S.J., Yang Y.C., Amoaku W.M., and United Kingdom PDT Users Group. Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series. Ophthalmology 112 (2005) 1227-1231
6. Caldwell R.B., Bartoli M., Behzadian M.A., El-Remessy A.E., Al-Shabrawey M., Platt D.H., Liou G.I., and Caldwell R.W. Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Curr. Drug Targets 6 (2005) 511-524
7. Campochiaro P.A. Retinal and choroidal neovascularization. J. Cell. Physiol. 184 (2000) 301-310
8. Cohen S.Y., Laroche A., Leguen Y., Soubrane G., and Coscas G.J. Etiology of choroidal neovascularization in young patients. Ophthalmology 103 (1996) 1241-1244
9. Cui J.Z., Kimura H., Spee C., Thumann G., Hinton D.R., and Ryan S.J. Natural history of choroidal neovascularization induced by vascular endothelial growth factor in the primate. Graefes Arch. Clin. Exp. Ophthalmol. 238 (2000) 326-333
10. elDirini A.A., Ogden T.E., and Ryan S.J. Subretinal endophotocoagulation. A new model of subretinal neovascularization in the rabbit. Retina 11 (1991) 244-249
11. Ferris III F.L., Fine S.L., and Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch. Ophthalmol. 102 (1984) 1640-1642
12. Frank R.N., Das A., and Weber M.L. A model of subretinal neovascularization in the pigmented rat. Curr. Eye Res. 8 (1989) 239-247
13. Frank R.N., Amin R.H., Eliott D., Puklin J.E., and Abrams G.W. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am. J. Ophthalmol. 122 (1996) 393-403
14. Frennesson C.I., and Nilsson S.E. Encouraging results of photodynamic therapy with Visudyne in a clinical patient material of age-related macular degeneration. Acta Ophthalmol. Scand. 82 (2004) 645-650
15. Fridman R., Sweeney T.M., Zain M., Martin G.R., and Kleinman H.K. Malignant transformation of NIH-3T3 cells after subcutaneous co-injection with a reconstituted basement membrane (matrigel). Int. J. Cancer 51 (1992) 740-744
16. Fukuchi T., Takahashi K., Shou K., and Matsumura M. Optical coherence tomography (OCT) findings in normal retina and laser-induced choroidal neovascularization in rats. Graefes Arch. Clin. Exp. Ophthalmol. 239 (2001) 41-46
17. Ghosh F., Bruun A., and Ehinger B. Graft-host connections in long-term full-thickness embryonic rabbit retinal transplants. Invest. Ophthalmol. Vis. Sci. 40 (1999) 126-132
18. Ghosh F., Johansson K., and Ehinger B. Long-term full-thickness embryonic rabbit retinal transplants. Invest. Ophthalmol. Vis. Sci. 40 (1999) 133-142
19. Grindle C.F., and Marshall J. Ageing changes in Bruch's membrane and their functional implications. Trans. Ophthalmol. Soc. U.K. 98 (1978) 172-175
20. Halliwell B. Oxidants and human disease: some new concepts. FASEB J. 1 (1987) 358-364
21. Herve M.A., Buteau-Lozano H., Mourah S., Calvo F., and Perrot-Applanat M. VEGF189 stimulates endothelial cells proliferation and migration in vitro and up-regulates the expression of Flk-1/KDR mRNA. Exp. Cell Res. 309 (2005) 24-31
22. Hollick E.J., Goble R.R., Knowles P.J., Ramsey M.C., Deutsch G., and Casswell A.G. Radiotherapy treatment of age-related subfoveal neovascular membranes in patients with good vision. Eye 10 (1996) 609-616
23. Ishibashi T., Miller H., Orr G., Sorgente N., and Ryan S.J. Morphologic observations on experimental subretinal neovascularization in the monkey. Invest. Ophthalmol. Vis. Sci. 28 (1987) 1116-1130
24. Ishida K., Yoshimura N., Mandai M., and Honda Y. Inhibitory effect of TNP-470 on experimental choroidal neovascularization in a rat model. Invest. Ophthalmol. Vis. Sci. 40 (1999) 1512-1519
25. Kaiser R.S., Berger J.W., Williams G.A., Tolentino M.J., Maguire A.M., Alexander J., Madjarov B., and Margherio R.M. Variability in fluorescein angiography interpretation for photodynamic therapy in age-related macular degeneration. Retina 22 (2002) 683-690
26. Kaplan H.J., Tezel T.H., Berger A.S., and Del Priore L.V. Retinal transplantation. Chem. Immunol. 73 (1999) 207-219
27. Kim S.G., Lee S.C., Seong Y.S., Kim S.W., and Kwon O.W. Choroidal neovascularization characteristics and its size in optical coherence tomography. Yonsei Med. J. 44 (2003) 821-827
28. Kimura H., Sakamoto T., Hinton D.R., Spee C., Ogura Y., Tabata Y., Ikada Y., and Ryan S.J. A new model of subretinal neovascularization in the rabbit. Invest. Ophthalmol. Vis. Sci. 36 (1995) 2110-2119
29. Kleinman H.K., Graf J., Iwamoto Y., Kitten G.T., Ogle R.C., Sasaki M., Yamada Y., Martin G.R., and Luckenbill-Edds L. Role of basement membranes in cell differentiation. Ann. N.Y. Acad. Sci. 513 (1987) 134-145
30. Kragh M., Hjarnaa P.J., Bramm E., and Binderup L. A versatile in vivo chamber angiogenesis assay for measuring anti-angiogenic activity in mice. Oncol. Rep. 11 (2004) 303-307
31. Kvanta A., Algvere P.V., Berglin L., and Seregard S. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest. Ophthalmol. Vis. Sci. 37 (1996) 1929-1934
32. Kwak N., Okamoto N., Wood J.M., and Campochiaro P.A. VEGF is major stimulator in model of choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 41 (2000) 3158-3164
33. Lanzetta P., Pirracchio A., and Bandello F. Optical coherence tomography of subfoveal choroidal neovascularization treated with transpupillary thermotherapy. Semin. Ophthalmol. 16 (2001) 97-100
34. Lip P.L., Blann A.D., Hope-Ross M., Gibson J.M., and Lip G.Y. Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. Ophthalmology 108 (2001) 705-710
35. Lopez P.F., Sippy B.D., Lambert H.M., Thach A.B., and Hinton D.R. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest. Ophthalmol. Vis. Sci. 37 (1996) 855-868
36. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Arch. Ophthalmol. 109 (1991) 1242-1257
37. Miller J.W., Adamis A.P., Shima D.T., D'Amore P.A., Moulton R.S., O'Reilly M.S., Folkman J., Dvorak H.F., Brown L.F., Berse B., Yeo T.K., and Yeo K.T. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am. J. Pathol. 145 (1994) 574-584
38. Murata T., Cui J., Taba K.E., Oh J.Y., Spee C., Hinton D.R., and Ryan S.J. The possibility of gene therapy for the treatment of choroidal neovascularization. Ophthalmology 107 (2000) 1364-1373
39. Okamoto N., Tobe T., Hackett S.F., Ozaki H., Vinores M.A., LaRochelle W., Zack D.J., and Campochiaro P.A. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am. J. Pathol. 151 (1997) 281-291
40. Ozaki H., Hayashi H., Vinores S.A., Moromizato Y., Campochiaro P.A., and Oshima K. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. Exp. Eye Res. 64 (1997) 505-517
41. Ozaki H., Okamoto N., Ortega S., Chang M., Ozaki K., Sadda S., Vinores M.A., Derevjanik N., Zack D.J., Basilico C., and Campochiaro P.A. Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization. Am. J. Pathol. 153 (1998) 757-765
42. Passaniti A., Taylor R.M., Pili R., Guo Y., Long P.V., Haney J.A., Pauly R.R., Grant D.S., and Martin G.R. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67 (1992) 519-528
43. Penfold P., Killingsworth M., and Sarks S. An ultrastructural study of the role of leucocytes and fibroblasts in the breakdown of Bruch's membrane. Aust. J. Ophthalmol. 12 (1984) 23-31
44. Penfold P.L., Killingsworth M.C., and Sarks S.H. Senile macular degeneration: the involvement of immunocompetent cells. Graefes Arch. Clin. Exp. Ophthalmol. 223 (1985) 69-76
45. Penfold P.L., Killingsworth M.C., and Sarks S.H. Senile macular degeneration. The involvement of giant cells in atrophy of the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 27 (1986) 364-371
46. Ryan Jr. S.J. De novo subretinal neovascularization in the histoplasmosis syndrome. Arch. Ophthalmol. 94 (1976) 321-327
47. Ryan S.J. Subretinal neovascularization. Natural history of an experimental model. Arch. Ophthalmol. 100 (1982) 1804-1809
48. Saishin Y., Saishin Y., Takahashi K., Lima e Silva R., Hylton D., Rudge J.S., Wiegand S.J., and Campochiaro P.A. VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier. J. Cell. Physiol. 195 (2003) 241-248
49. Senger D.R., Claffey K.P., Benes J.E., Perruzzi C.A., Sergiou A.P., and Detmar M. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 13612-13617
50. Tamai K., Spaide R.F., Ellis E.A., Iwabuchi S., Ogura Y., and Armstrong D. Lipid hydroperoxide stimulates subretinal choroidal neovascularization in the rabbit. Exp. Eye Res. 74 (2002) 301-308
51. Wang F., Rendahl K.G., Manning W.C., Quiroz D., Coyne M., and Miller S.S. AAV-mediated expression of vascular endothelial growth factor induces choroidal neovascularization in rat. Invest. Ophthalmol. Vis. Sci. 44 (2003) 781-790
52. Winkler B.S., Boulton M.E., Gottsch J.D., and Sternberg P. Oxidative damage and age-related macular degeneration. Mol. Vis. 5 (1999) 32
53. Yasukawa T., Kimura H., Tabata Y., Kamizuru H., Miyamoto H., Honda Y., and Ogura Y. Targeting of interferon to choroidal neovascularization by use of dextran and metal coordination. Invest. Ophthalmol. Vis. Sci. 43 (2002) 842-848
54. Zacks D.N., Ezra E., Terada Y., Michaud N., Connolly E., Gragoudas E.S., and Miller J.W. Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization. Invest. Ophthalmol. Vis. Sci. 43 (2002) 2384-2391